Vitamin D in Cutaneous T-Cell Lymphoma
Cutaneous T-cell lymphoma (CTCL) is characterized by the proliferation of malignant T cells in inflamed skin lesions. Mycosis fungoides (MF)—the most common variant of CTCL—often presents with skin lesions around the abdomen and buttocks (“bathing suit” distribution), i.e., in skin areas devoid of s...
Main Authors: | August-Witte Feentved Ødum, Carsten Geisler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/13/6/503 |
Similar Items
-
Epidemiological Characteristics and the Development of Prognostic Nomograms of Patients With HIV-Associated Cutaneous T-Cell Lymphoma
by: Zheng Yang, et al.
Published: (2022-03-01) -
B-cell lymphoma 2 inhibitor venetoclax treatment of a patient with cutaneous T-cell lymphoma
by: Amber Loren O. King, BA, et al.
Published: (2021-02-01) -
Decreased keratinocyte Proline‐Rich protein expression in cutaneous T‐cell lymphoma
by: Teruyoshi Hisamoto, et al.
Published: (2022-08-01) -
Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries
by: Chalid Assaf, et al.
Published: (2021-12-01) -
MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas
by: Maria Gluud, et al.
Published: (2020-05-01)